Healthtech Growth Investors & VC Firms
1213 firms in this list, with a median first check of $1.1M. 281 of them lead rounds. Generated from verified public data and updated continuously.
Technology Innovation Agency
PretoriaPre-Seed–Growth
The Rise Fund
San FranciscoGrowth
ZEISS Ventures
OberkochenSeed–Growth
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Late Stage$1.1M – $198M
1 person
Blue Heron Capital
RichmondGrowth
5 people
Alibaba Entrepreneurs Fund
Hong KongSeed–Late Stage$1.2M – $150M
2 people
Baidu Ventures
BeijingSeed–Growth$1.4M – $145M
2 people
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
Nissay Capital
TokyoPre-Seed–Late Stage$610K – $71M
1 person
Annox Capital
BirminghamSeed–Late Stage$100K – $30M
1 person
FFG Venture Business Partners
FukuokaPre-Seed–Late Stage$1M – $50M
1 person
Japan Asia Investment
TokyoPre-Seed–Late Stage$1M – $10M
1 person
Mitsubishi UFJ Capital
TokyoPre-Seed–Late Stage$952K – $269M
CIBC
ChicagoPre-Seed–Late Stage$1.5M – $29.2M
Braxton Capital Ventures Pte Ltd.
SingaporeSeed–Late Stage
3 people
Capricornio Capital
Growth–Late Stage$1M – $10M
Cdh Venture Management Company Limited
Hong KongSeed–Late Stage$7.1M – $300M
Harriet Ventures
Series A–Growth$500K – $50M
IMM Investment
KangnamPre-Seed–Growth$3M – $54M
Jeneration Capital
Grand Cayman, KySeries A–Growth
3 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$1M – $30M
Oriza Holdings
SuzhouSeed–Growth$1.7M – $200M
World Innovation Lab (WiL)
Palo AltoPre-Seed–Late Stage$5M – $30M
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
Related lists
Growth Investors & VC Firms (4757)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Enterprise Software Growth Investors & VC Firms (1186)
Data sourced from public filings and firms' own websites — see our methodology.





